Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: A randomized, controlled cross-over trial

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Asher, Gary N ^a   Viera, Anthony J ^a   Weaver, Mark A ^a   Dominik, Rosalie ^b   Caughey, Melissa ^a   Hinderliter, Alan L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

Crataegus; Flow mediated dilation; Hawthorn; Hypertension; Phase I; Prehypertension

Indexed keywords

CRATAEGUS EXTRACT; NITRIC OXIDE; PLACEBO; PROCYANIDIN; BIFLAVONOID; CATECHIN; PLANT EXTRACT; PROANTHOCYANIDIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CRATAEGUS; CROSSOVER PROCEDURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FLOW MEDIATED DILATION; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; NAUSEA; PREHYPERTENSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; VASODILATATION; AGED; BLOOD; BLOOD PRESSURE; CHEMISTRY; CIRCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; MIDDLE AGED; PATIENT ATTITUDE; PHYTOTHERAPY; STANDARD;

ADULT; AGED; BIFLAVONOIDS; BLOOD CIRCULATION; BLOOD PRESSURE; BRACHIAL ARTERY; CATECHIN; CRATAEGUS; CROSS-OVER STUDIES; HUMANS; HYPERTENSION; MIDDLE AGED; NITRIC OXIDE; PATIENT ACCEPTANCE OF HEALTH CARE; PHYTOTHERAPY; PLANT EXTRACTS; PROANTHOCYANIDINS; VASODILATION;

EID: 84858995083     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-26     Document Type: Article

References (37)

1. Hawthorn Berry. American Herbal Pharmacopoeia 1999, 24. Scotts Valley: AHP, Upton R.
2. Chang Q, Zuo Z, Harrison F, Chow MS. Hawthorn. J Clin Pharmacol 2002, 42(6):605-612. 10.1177/00970002042006003, 12043949.
3. Brixius K, Willms S, Napp A, Tossios P, Ladage D, Bloch W, Mehlhorn U, Schwinger RH. Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc Drugs Ther 2006, 20(3):177-184. 10.1007/s10557-006-8723-7, 16779533.
4. Kim SH, Kang KW, Kim KW, Kim ND. Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci 2000, 67(2):121-131. 10.1016/S0024-3205(00)00608-1, 10901280.
5. Koch E, Chatterjee S. Crataegus extract WS 1442 enhances coronary flow in the isolated rat heart by endothelial release of nitric oxide. Naunyn Schmiedebergs Arch Pharmacol 2000, 361(Suppl):R48.
6. Ellingwood F. JU L: American Materia Medica, Therapeutics and Pharmacognosy. 1915, Evanston: Ellingwood's Therapeutist.
7. ESCOP Monographs. 2003, Stuttgart: Thieme, 2.
8. Guo R, Pittler MH, Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev 2008, (1):CD005312.
9. Asgary S, Naderi GH, Sadeghi M, Kelishadi R, Amiri M. Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study. Drugs Exp Clin Res 2004, 30(5-6):221-225.
10. Walker AF, Marakis G, Morris AP, Robinson PA. Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension. Phytother Res 2002, 16(1):48-54. 10.1002/ptr.947, 11807965.
11. Walker AF, Marakis G, Simpson E, Hope JL, Robinson PA, Hassanein M, Simpson HC. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br J Gen Pract 2006, 56(527):437-443. 1839018, 16762125.
12. Chen JD, Wu YZ, Tao ZL, Chen ZM, Liu XP. Hawthorn (shan zha) drink and its lowering effect on blood lipid levels in humans and rats. World Rev Nutr Diet 1995, 77:147-154.
13. Rajendran S, Deepalakshmi PD, Parasakthy K, Devaraj H, Devaraj SN. Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis 1996, 123(1-2):235-241. 10.1016/0021-9150(96)05813-3, 8782854.
14. Shanthi S, Parasakthy K, Deepalakshmi PD, Devaraj SN. Hypolipidemic activity of tincture of Crataegus in rats. Indian J Biochem Biophys 1994, 31(2):143-146.
15. Shanthi S, Parasakthy K, Deepalakshmi PD, Niranjjali D. Protective effect of tincture of Crataegus on wxidative stress in experimental atherosclerosis in rats. J Clin Biochem Nutr 1996, 20:211-223.
16. Zhang Z, Ho WK, Huang Y, James AE, Lam LW, Chen ZY. Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet. J Nutr 2002, 132(1):5-10.
17. Moens AL, Goovaerts I, Claeys MJ, Vrints CJ. Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool?. Chest 2005, 127(6):2254-2263. 10.1378/chest.127.6.2254, 15947345.
18. Tauchert M. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 2002, 143(5):910-915. 10.1067/mhj.2002.121463, 12040357.
19. Tauchert M, Gildor A, Lipinski J. [High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure]. Herz 1999, 24(6):465-474. discussion 475, 10.1007/BF03044432, 10546150.
20. Weikl A, Assmus KD, Neukum-Schmidt A, Schmitz J, Zapfe G, Noh HS, Siegrist J. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)]. Fortschr Med 1996, 114(24):291-296.
21. Chang Q, Zuo Z, Ho WK, Chow MS. Comparison of the pharmacokinetics of hawthorn phenolics in extract versus individual pure compound. J Clin Pharmacol 2005, 45(1):106-112. 10.1177/0091270004270500, 15601812.
22. Wang B, Wang X, Gong L. The Construction of a Williams Design and Randomization in Cross-Over Clinical Trials Using SAS. Journal of Statistical Software 2009, 29. Code snippet 1, pp1-10.
23. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39(2):257-265. 10.1016/S0735-1097(01)01746-6, 11788217.
24. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005, 45(1):142-161.
25. Dmitrienko A, Fritsch K, Hsu J, Ruberg S. Design and analysis of dose-ranging clinical studies. Pharmaceutical Statistics Using SAS: A Practical Guide 2007, 274-311. Cary: SAS Institute, Inc, Dmitrienko A, Chuangstein C, Ralph D'Agostino S.
26. Donald AE, Halcox JP, Charakida M, Storry C, Wallace SM, Cole TJ, Friberg P, Deanfield JE. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 2008, 51(20):1959-1964. 10.1016/j.jacc.2008.02.044, 18482664.
27. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990, 323(1):22-27. 10.1056/NEJM199007053230105, 2355955.
28. Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, Di Tullio M, Boden-Albala B, Sacco R, Homma S. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007, 192(1):197-203. 10.1016/j.atherosclerosis.2006.05.005, 16762358.
29. Chen ZY, Zhang ZS, Kwan KY, Zhu M, Ho WK, Huang Y. Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci 1998, 63(22):1983-1991. 10.1016/S0024-3205(98)00476-7, 9839542.
30. Vierling W, Brand N, Gaedcke F, Sensch KH, Schneider E, Scholz M. Investigation of the pharmaceutical and pharmacological equivalence of different Hawthorn extracts. Phytomedicine 2003, 10(1):8-16. 10.1078/094471103321648601, 12622458.
31. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993, 88(1):77-81.
32. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996, 27(4):849-853.
33. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 2001, 38(2):274-279.
34. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, et al. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 2006, 295(1):58-64. 10.1001/jama.295.1.58, 16391217.
35. Zand J, Lanza F, Garg HK, Bryan NS. All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide production and reduces triglycerides in humans. Nutr Res 2011, 31(4):262-269. 10.1016/j.nutres.2011.03.008, 21530799.
36. Feelisch M, Fernandez BO, Bryan NS, Garcia-Saura MF, Bauer S, Whitlock DR, Ford PC, Janero DR, Rodriguez J, Ashrafian H. Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and -scavenging systems. J Biol Chem 2008, 283(49):33927-33934. 10.1074/jbc.M806654200, 2590701, 18835812.
37. Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs 2000, Newton, MA: IntegrativMedicine.